Summary
M2 EQUITYBITES-June 28, 2011--Diamyd Medical announces weak results for diabetes vaccine in phase II trial
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Ii Trial
28 June 2011 - Swedish pharma company Diamyd Medical AB (STO: DIAM B) said toda...
See the full content of this document
Sponsored links
